<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In adipocytes, <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> are closely associated with <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e>, including <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the molecular mechanisms underlying these <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> have not been thoroughly elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we demonstrate that overexpression of <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate dehydrogenase (G6PD) in adipocytes stimulates <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:mp ids='MP_0001845'>inflammatory responses</z:mp>, thus affecting the neighboring macrophages </plain></SENT>
<SENT sid="3" pm="."><plain>Adipogenic G6PD overexpression promotes the expression of pro-oxidative enzymes, including inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase and <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase, and the activation of nuclear factor-kappaB (NF-kappaB) signaling, which eventually leads to the dysregulation of adipocytokines and inflammatory signals </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, secretory factors from G6PD-overexpressing adipocytes stimulate macrophages to express more proinflammatory cytokines and to be recruited to the adipocytes; this would cause <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory conditions in the adipose tissue of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These effects of G6PD overexpression in adipocytes were abolished by pretreatment with NF-kappaB inhibitors or <z:chebi fb="11" ids="22586">antioxidant</z:chebi> drugs </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, we propose that a high level of G6PD in adipocytes may mediate the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> in <z:hpo ids='HP_0001513'>obesity</z:hpo> by increasing the <z:mp ids='MP_0003674'>oxidative stress</z:mp> and inflammatory signals </plain></SENT>
</text></document>